Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trialKeith J. Chappell, Trent P. Munro|The Lancet Infectious Diseases|2021Cited by 119
Accelerating patient access to novel biologics using stable pool‐derived product for non‐clinical studies and single clone‐derived product for clinical studiesTrent P. Munro, Chetan T. Goudar, Sabrina A. Benchaar et al.|Biotechnology Progress|2017Cited by 35
Modification and validation of the Bluebelle Wound Healing Questionnaire (WHQ) for assessing surgical site infection in wounds healing by secondary intentionRhiannon Macefield, John Fletcher, Laura Mandefield et al.|Journal of Tissue Viability|2025Cited by 1